Link to this page
Assessment of Indian Economy During Covid-19
Last uploaded:
July 5, 2021
Jump to:
| Preferred Name | telavancin | |
| Synonyms |
telavancin telavancine telavancinum telavancina N(3'')-[2-(decylamino)ethyl]-29-{[(phosphonomethyl)amino]methyl}vancomycin |
|
| Definitions |
A glycopeptide that is vancomycin substituted at position N-3'' by a 2-(decylamino)ethyl group and at position C-29 by a (phosphonomethyl)aminomethyl group. Used as its hydrochloride salt for treatment of adults with complicated skin and skin structure infections caused by bacteria. |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_71229 |
|
| charge |
0
|
|
| chemical effective in vitro against virus | ||
| chemical inhibits in vitro invasion of virus | ||
| database_cross_reference |
PMID:22890759 PMID:22867688 CAS:372151-71-8 PMID:23030322 PMID:22252799 PMID:21740298 Patent:WO2008085913 PMID:22416054 Wikipedia:Telavancin PMID:22248980 PMID:22508304 PMID:23129464 Reaxys:9988046 PMID:22123693 PMID:22668202 PMID:22078909 Drug_Central:4116 PMID:22855107 PMID:23083812 PMID:22252798 PMID:22491686 PMID:22575272 PMID:22174040 PMID:18443115 PMID:22916113 PMID:22619476 PMID:22411615 PMID:22687502 PMID:22547931
|
|
| definition |
A glycopeptide that is vancomycin substituted at position N-3'' by a 2-(decylamino)ethyl group and at position C-29 by a (phosphonomethyl)aminomethyl group. Used as its hydrochloride salt for treatment of adults with complicated skin and skin structure infections caused by bacteria.
|
|
| definition source |
PMID: 26953343; PMID: 28855003; PMID: 16081529
|
|
| formula |
C80H106Cl2N11O27P
|
|
| has functional parent | ||
| has role | ||
| has_obo_namespace |
chebi_ontology
|
|
| has_related_synonym |
telavancin telavancine telavancinum telavancina N(3'')-[2-(decylamino)ethyl]-29-{[(phosphonomethyl)amino]methyl}vancomycin
|
|
| id |
CHEBI:71229
|
|
| imported from | ||
| in_subset | ||
| inchi |
InChI=1S/C80H106Cl2N11O27P/c1-7-8-9-10-11-12-13-14-21-85-22-23-87-80(5)32-57(115-37(4)71(80)103)119-70-68(102)67(101)55(34-94)118-79(70)120-69-53-28-41-29-54(69)117-52-20-17-40(27-46(52)82)65(99)63-77(109)91-61(78(110)111)43-30-50(96)44(33-86-35-121(112,113)114)66(100)58(43)42-25-38(15-18-49(42)95)59(74(106)93-63)90-75(107)60(41)89-73(105)48(31-56(83)97)88-76(108)62(92-72(104)47(84-6)24-36(2)3)64(98)39-16-19-51(116-53)45(81)26-39/h15-20,25-30,36-37,47-48,55,57,59-65,67-68,70-71,79,84-87,94-96,98-103H,7-14,21-24,31-35H2,1-6H3,(H2,83,97)(H,88,108)(H,89,105)(H,90,107)(H,91,109)(H,92,104)(H,93,106)(H,110,111)(H2,112,113,114)/t37-,47+,48-,55+,57-,59+,60+,61-,62+,63-,64+,65+,67+,68-,70+,71+,79-,80-/m0/s1
|
|
| inchikey |
ONUMZHGUFYIKPM-MXNFEBESSA-N
|
|
| label |
telavancin
|
|
| mass |
1755.63500
|
|
| monoisotopicmass |
1753.63743
|
|
| notation |
CHEBI:71229
|
|
| prefLabel |
telavancin
|
|
| smiles |
CCCCCCCCCCNCCN[C@@]1(C)C[C@@H](O[C@@H](C)[C@H]1O)O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]4C(=O)N[C@@H]([C@H](O)c5ccc(Oc1cc3c2)c(Cl)c5)C(=O)N[C@H](C(O)=O)c1cc(O)c(CNCP(O)(O)=O)c(O)c1-c1cc4ccc1O
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping